{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:46:43Z","timestamp":1791406003480,"version":"4.3.3"},"reference-count":60,"publisher":"Microbiology Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4,1]]},"abstract":"<jats:p>Human cytomegalovirus (HCMV) is a large DNA virus belonging to the subfamily<jats:italic>Betaherpesvirinae<\/jats:italic>. Haematopoietic cells of the myeloid lineage have been shown to harbour latent HCMV. However, following terminal differentiation of these cells, virus is reactivated, and in an immunocompromised host acute infection can occur. It is currently unknown which viral and cellular factors are involved in regulating the switch between lytic and latent infections. Cyclophilin A (CyPA) is a cellular protein that acts as a major factor in virus replication and\/or virion maturation for a number of different viruses, including human immunodeficiency virus, hepatitis C virus, murine cytomegalovirus, influenza A virus and vaccinia virus. This study investigated the role of CyPA during HCMV infection. CyPA expression was silenced in human foreskin fibroblast (HF) and THP-1 cells using small interfering RNA (siRNA) technology, or the cells were treated with cyclosporin A (CsA) to inhibit CyPA activity. Silencing CyPA in HF cells with siRNA resulted in an overall reduction in virus production characterized by delayed expression of immediate-early (IE) proteins, decreased viral DNA loads and reduced titres. Furthermore, silencing of CyPA in THP-1 cells pre- and post-differentiation prevented IE protein expression and virus reactivation from a non-productive state. Interestingly, it was observed that treatment of THP-1 cells with CsA prevented the cells from establishing a fully latent infection. In summary, these results demonstrate that CyPA expression is an important factor in HCMV IE protein expression and virus production in lytically infected HF cells, and is a major component in virus reactivation from infected THP-1 cells.<\/jats:p>","DOI":"10.1099\/vir.0.037309-0","type":"journal-article","created":{"date-parts":[[2012,1,12]],"date-time":"2012-01-12T04:10:41Z","timestamp":1326341441000},"page":"722-732","source":"Crossref","is-referenced-by-count":43,"title":["Cyclophilin A is required for efficient human cytomegalovirus DNA replication and reactivation"],"prefix":"10.1099","volume":"93","author":[{"given":"Lisa R.","family":"Keyes","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology and Graduate Program in Cell and Molecular Biology, University of Nevada, Reno, NV 89557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana G.","family":"Bego","sequence":"additional","affiliation":[{"name":"Institut de Recherches Cliniques de Montr\u00e9al (IRCM), 110 avenue des Pins Ouest, Montr\u00e9al, QC H2W 1R7, Canada"},{"name":"Department of Microbiology and Immunology and Graduate Program in Cell and Molecular Biology, University of Nevada, Reno, NV 89557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melisa","family":"Soland","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology and Graduate Program in Cell and Molecular Biology, University of Nevada, Reno, NV 89557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"St Jeor","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology and Graduate Program in Cell and Molecular Biology, University of Nevada, Reno, NV 89557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"r1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02041244"},{"key":"r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2005.11.012"},{"key":"r3","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.13.5949-5957.2001"},{"key":"r4","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.19074-0"},{"key":"r5","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1128\/JVI.70.6.3551-3560.1996","article-title":"Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription","volume":"70","author":"Braaten","year":"1996","journal-title":"J Virol"},{"key":"r6","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910440122"},{"key":"r7","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.16.9052-9068.2003"},{"key":"r8","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.007625"},{"key":"r9","first-page":"113","article-title":"Cytomegalovirus infection in patients with HIV infection","volume":"66","author":"Cheung","year":"1999","journal-title":"Mt Sinai J Med"},{"key":"r10","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.101709"},{"key":"r11","first-page":"394","article-title":"A macrophage-like cell model for testing anti-CMV drugs","volume":"45","author":"Delannoy","year":"1997","journal-title":"Pathol Biol (Paris)"},{"key":"r12","first-page":"911","article-title":"Cyclophilin inhibitors for the treatment of HCV infection","volume":"11","author":"Fischer","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"r13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22131"},{"key":"r14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2006.08.001"},{"key":"r15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.7.3937"},{"key":"r16","doi-asserted-by":"publisher","DOI":"10.1126\/science.6238408"},{"key":"r17","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199509000-00013"},{"key":"r18","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(99)00064-5"},{"key":"r19","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2006.07.021"},{"key":"r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2011.01.011"},{"key":"r21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000546"},{"key":"r22","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00261-07"},{"key":"r23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05056.x"},{"key":"r24","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(01)00007-9"},{"key":"r25","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.342"},{"key":"r26","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2004.02.011"},{"key":"r27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1016-8478(23)13505-9","article-title":"Factors affecting human cytomegalovirus gene expression in human monocyte cell lines","volume":"9","author":"Lee","year":"1999","journal-title":"Mol Cells"},{"key":"r28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000309"},{"key":"r29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2009.02.051"},{"key":"r30","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00682-09"},{"key":"r31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-5822.2009.01286.x"},{"key":"r32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02550-08"},{"key":"r33","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00310-06"},{"key":"r34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1182\/blood.V80.1.170.bloodjournal801170","article-title":"Infection of hematopoietic progenitor cells by human cytomegalovirus","volume":"80","author":"Maciejewski","year":"1992","journal-title":"Blood"},{"key":"r35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-11-90"},{"key":"r36","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.031"},{"key":"r37","doi-asserted-by":"publisher","DOI":"10.1007\/BF00191544"},{"key":"r38","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-102"},{"key":"r39","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21102"},{"key":"r40","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000229039.87735.76"},{"key":"r41","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1128\/JVI.73.7.5663-5670.1999","article-title":"A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency","volume":"73","author":"Prichard","year":"1999","journal-title":"J Virol"},{"key":"r42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1099\/0022-1317-81-2-393","article-title":"Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus","volume":"81","author":"Riegler","year":"2000","journal-title":"J Gen Virol"},{"key":"r43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4049\/jimmunol.177.1.443","article-title":"Novel activities of cyclophilin A and cyclosporin A during HIV-1 infection of primary lymphocytes and macrophages","volume":"177","author":"Saini","year":"2006","journal-title":"J Immunol"},{"key":"r44","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-77349-8_4"},{"key":"r45","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)80014-3"},{"key":"r46","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2006.06.011"},{"key":"r47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1472-6807-10-31","article-title":"The intriguing cyclophilin A\u2013HIV-1 Vpr interaction: prolyl cis\/trans isomerisation catalysis and specific binding","volume":"10","author":"Solbak","year":"2010","journal-title":"BMC Struct Biol"},{"key":"r48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M311406200"},{"key":"r49","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.299.6704.897"},{"key":"r50","doi-asserted-by":"publisher","DOI":"10.1038\/ng.375"},{"key":"r51","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-72-9-2059"},{"key":"r52","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-74-2-265"},{"key":"r53","doi-asserted-by":"publisher","DOI":"10.1006\/mpat.1994.1037"},{"key":"r54","doi-asserted-by":"publisher","DOI":"10.2174\/1568008013341334"},{"key":"r55","first-page":"213","article-title":"Alisporivir, a cyclosporin derivative that selectively inhibits cyclophilin, for the treatment of HCV infection","volume":"11","author":"Watashi","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"r56","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.4049\/jimmunol.140.5.1625","article-title":"Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line","volume":"140","author":"Weinshenker","year":"1988","journal-title":"J Immunol"},{"key":"r57","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1995.1112"},{"key":"r58","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02614-07"},{"key":"r59","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2007.01.036"},{"key":"r60","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1182\/blood.V90.6.2482","article-title":"Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: model of HCMV latency","volume":"90","author":"Zhuravskaya","year":"1997","journal-title":"Blood"}],"container-title":["Journal of General Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.037309-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T16:06:10Z","timestamp":1713369970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.037309-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,1]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4,1]]}},"URL":"https:\/\/doi.org\/10.1099\/vir.0.037309-0","relation":{},"ISSN":["0022-1317","1465-2099"],"issn-type":[{"value":"0022-1317","type":"print"},{"value":"1465-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,1]]}}}